At-home microbiome testing is taking off. Can we trust them?

First, the good news: I have 133 microbial species living in my gut. This is a collection rated as “excellent” by NirvanaBiome, the Germantown, Maryland, company that analyzed my stool sample. The company based its rating on the overall diversity of my gut’s residents as well as my levels of specific beneficial and undesirable species.

But then came a second, less promising assessment: Viome in Bellevue, Washington, identified only 61 types of microorganisms active in my gut and suggested that some of them were not functioning optimally. Viome recommended dietary changes and suggested personalized supplements to improve my health.

I was intrigued by the results, but also baffled by the different messages. It’s not an uncommon response, says microbiologist Rob Knight, director of the Center for Microbiome Innovation at the University of California, San Diego. When scientists tested a handful of microbiome test kits side by side in formal studies, they found wide discrepancies in results. These differences make it difficult to truly understand or trust a given provider’s results, says Diane Hoffmann, director of the Law and Health Care program at the University of Maryland in Baltimore, co-author of one of these studies.

Companies stay true to their products. “Of course there is variability,” says Kelly Moffat, director of operations for Cmbio in Germantown, which does the lab work and genetic sequencing for NirvanaBiome. “There has to be some because these are complex tests.”

Momo Vuyisich, scientific director of the Viome laboratory in Bothwell, Washington, also says he was not surprised by the degree of variation found by formal studies. Laboratories use different methods to extract, sequence and analyze microbial genetic material. Viome, for example, sequences RNA rather than DNA, allowing it to discover the activity of microbial genes, rather than just the presence of genes. Vuyisich argues that this is more about human health. And he says that while each method has biases, as long as the consumer stays with the same provider, it should produce comparable results over time.

Interest in this type of testing is booming. “There is so much excitement and excitement from the public about the microbiome,” Knight says. Some clients are simply curious about the microscopic beings that live inside them and potentially affect their health; others suffer from health conditions such as irritable bowel syndrome and hope their gut microbes will reveal the underlying cause or a path to better health.

Although people can order tests and follow their recommendations without the help of a healthcare professional, some people take the results to their doctor. “I groan when I see someone come in with a microbiome test,” says Fergus Shanahan, a gastroenterologist and immunologist at University College Cork in Ireland, who has spent much of his career studying the microbiome. For someone struggling with gut health issues, a consumer microbiome profile is generally not specific enough to be useful. And if there is a fear of infection, such as Clostridioides difficileit is simpler to look for known pathogens than to assess the entire microbial community.

Microbiologists and gastroenterologists who spoke with Nature There is general agreement that microbiome testing has the potential to both reflect and promote health, but many argue that the science is not yet mature enough to support microbiome testing for most consumers. They say the limited clinical utility of current consumer tests may make them poor value for money (costing between US$100 and US$300). Experts warn that following advice that doesn’t come from clinicians could lead clients to adopt unnecessarily restrictive diets or delay proper medical evaluation. Critics say consumer microbiome testing requires greater regulatory review and oversight.

“This is a booming industry,” says genomicist Jacques Ravel, director of the Center for Advanced Microbiome Research and Innovation at the University of Maryland School of Medicine in Baltimore and co-author of one of the studies that tested several vendors. When it comes to testing methods, he says, “there is no standard.”

Moffat says: “I think the jury is out on exactly what we can actually do today based on this data. » But she says microbiome profiles, combined with other tests such as gut metabolomics, could provide interesting and useful health insights.

An attractive proposition

The gut microbiome has become an incredible correlate of overall health. From immune system function to metabolism, skin disorders and mental health, study after study has established links between a person’s well-being and the billions of microbes that live in their digestive tract. The hypothesis of enumerating these species and evaluating their actions, in order to monitor and improve intestinal health in a personalized way, certainly seems attractive. Viome’s website, for example, promises: “No more trial and error…Follow a plan built specifically for you.” »

Companies can identify species and, based on these lists, infer what microbes are likely doing, such as making metabolites or causing inflammation. But performing even the simplest microbiological tests is expensive, says Alessandra Cervino, research director at PiLeJe, a science-based dietary supplement company in Paris. She claims her microbiome testing company, Luxia Scientific, closed in 2024 for financial reasons.

An open jar of kombucha, lit from above to glow red.

Some microbiome testing companies recommend fermented foods, like kombucha, for gut health.Credit: Deb Lindsey for The Washington Post via Getty

Many testing companies also offer lifestyle and nutritional advice or sell supplements. For example, Viome analyzed various functions performed by the microbes in my gut, such as digestive efficiency, gas production, and serotonin manufacturing. I then received a detailed eating plan — which told me to avoid broccoli and load up on pecans, among other suggestions — along with an offer of precision supplements and probiotics at a price of more than $150 per month. Although it’s difficult to change the composition of microbes in the gut, changes in diet or even just aging can alter their activities, Vuyisich says. The company recommends retesting every four to six months to check for changes and update the plan.

He cites 19 peer-reviewed publications from Viome as proof of the company’s rigor (see go.nature.com/4actdhq). For example, the company’s consumer analysis is supported, in part, by published data on how gut microbes influence individuals’ responses to glucose found in various foods, based on 550 people in the United States who collectively ate more than 30,000 meals while wearing glucometers.1. The company validated these results in another cohort in Japan, Vuyisich says, but this data is not published.

Microbiome tests are not created equal, says Tim Spector, a physician-researcher at King’s College London and co-founder of London-based ZOE, which offers microbiome tests and a supplement in addition to a gut health app I’ve been playing around with. According to Spector, ZOE’s products are backed by research conducted with thousands of people. “There are definitely some not-so-good players who are giving this field a bad name,” he says. “It’s not easy to do this well.”

Test the tests

There are also several ways to perform microbial testing; Companies adopt diverse approaches that yield disparate results, as at least two studies show. Scientists at the U.S. National Institute of Standards and Technology (NIST) in Gaithersburg, Maryland, shipped homogenized stool samples from one person to seven companies.2. NIST’s mission is to research and apply measurement standards. This experiment was a step toward understanding the diversity of testing options available, says one of the study’s authors, NIST microbiologist Stephanie Servetas, based in Sheridan, Wyoming. The researchers did not name the companies in their report because they wanted to focus attention on the comparison between tests rather than the perceived accuracy of an individual provider.

The result: “The companies produce surprisingly different results,” says co-author Scott Jackson, a molecular geneticist who led NIST’s microbiology program and is now a consultant in Saint Michaels, Maryland. “They couldn’t even agree on what was healthy and unhealthy,” Jackson says. The lists of microbes ranged from 34 to 906 identified genera; of which only 3 appeared in all reports. In fact, results were as varied from company to company as from person to person, even though all tests were performed on samples from the same individual.

A European and Canadian team obtained similar results by sending homogenized samples of a person’s stools to six companies, also anonymized. Three companies rated microbial diversity as “excellent” or “good”; two described it as “average”; one of them said it was “unfavorable”3. The results were so variable that at least some of them must have lacked validation or standardization, says co-author Céline Druart, executive director of the Pharmabiotic Research Institute (PRI) in Brussels, a nonprofit organization specializing in regulating microbiome innovations. “It’s very difficult to draw a conclusion,” she said.

This wide divergence in results is not surprising, says Jack Gilbert, director of the Microbiome and Metagenomics Center at the University of California, San Diego. The variation begins with sampling: pour a little feces into a tube, stab it with a corer, or run the sampler over used toilet paper; ship it as is, or…

Gn Health

Logo